Ahmed Rabee | Biomedical Sciences | Best Research Article Award

Published on by Cell Biologist

Best Research Article Award

Ahmed Rabee
Sulaiman Alrajhi University, Saudi Arabia

Ahmed Rabee
Affiliation Sulaiman Alrajhi University
Country Saudi Arabia
Google Scholar ID KmgzUgEAAAAJ
Documents 3
Citations 5
h-index 1
Subject Area Biomedical Sciences
Event World Cell Biologist Awards

Ahmed Rabee is a biomedical sciences researcher affiliated with Sulaiman Alrajhi University in Saudi Arabia. Available scholarly profile information identifies a research record comprising three documents, five citations, and an h-index of 1. These indicators provide a concise bibliometric overview of the currently documented scholarly output associated with the researcher profile. [1]

Abstract

Ahmed Rabee is affiliated with Sulaiman Alrajhi University, Saudi Arabia, and is associated with the field of Biomedical Sciences. The available scholarly record lists three documents, five citations, and an h-index of 1. [1] This article presents a structured academic recognition profile describing the researcher’s affiliation, scholarly record, research contribution, publication profile, research impact, and suitability for consideration for the Best Research Article Award.

The assessment is framed around transparent academic recognition principles, including the relevance and quality of research outputs, scholarly contribution, documented impact, and the appropriate interpretation of bibliometric indicators. Responsible research assessment recommends that quantitative metrics be considered alongside qualitative evidence rather than treated as standalone measures of research quality. [2]

Keywords

Ahmed Rabee; Biomedical Sciences; Sulaiman Alrajhi University; Best Research Article Award; scientific research; biomedical research; scholarly publications; research impact; bibliometrics; academic recognition.

Introduction

Biomedical sciences encompass a broad range of research disciplines concerned with biological mechanisms, disease processes, diagnostics, therapeutics, prevention, and the translation of scientific knowledge into health-related applications. Within this environment, research articles serve as important vehicles for communicating experimental observations, analytical findings, methodological developments, and scientific interpretations.

Academic recognition of a research article generally requires consideration of the article’s scientific question, methodological rigor, originality, evidence base, clarity, relevance, and contribution to the field. Bibliometric indicators may provide supporting information regarding scholarly dissemination, although such indicators require contextual interpretation. The Leiden Manifesto emphasizes that research metrics should support expert assessment rather than replace it. [4]

Research Profile

Ahmed Rabee is associated with Sulaiman Alrajhi University in Saudi Arabia and works within the broad subject area of Biomedical Sciences. The researcher is represented in Google Scholar by the identifier KmgzUgEAAAAJ. The available profile records three scholarly documents, five citations, and an h-index of 1. [1]

The documented publication record should be interpreted as a snapshot of indexed scholarly activity rather than a complete representation of all research undertaken by the researcher. Differences in indexing coverage, author-name variants, publication types, and database update schedules can affect bibliometric profiles. For this reason, quantitative indicators are most appropriately evaluated together with the underlying publications and their scientific context. [4]

Research Contributions

The available information places Ahmed Rabee’s scholarly activity within Biomedical Sciences. The documented publication record provides evidence of participation in scholarly communication, while the associated citation count indicates that the indexed publications have received measurable scholarly attention. [1]

A detailed evaluation of individual research contributions should consider the scientific problem addressed, study design, experimental or computational methodology, validity of the evidence, reproducibility, interpretation of findings, and relevance to the biomedical research community. Principles for responsible research assessment emphasize the importance of combining quantitative information with qualitative expert judgment. [4]

Publications

The supplied scholarly profile records three documents associated with Ahmed Rabee. The available information does not provide the titles, journals, publication years, author lists, or DOI identifiers of those individual publications. Accordingly, this page does not assign publication-specific titles or research findings that have not been independently supplied or verified.

For scholarly articles, persistent identifiers such as Digital Object Identifiers (DOIs) provide stable mechanisms for identifying and linking research outputs. The DOI system is widely used to support persistent scholarly citation and discovery. [3]

Research Impact

The available profile records five citations for three documents, with an h-index of 1. [1] These figures indicate documented scholarly use or citation of the researcher’s indexed publications. However, citation counts can vary among databases and over time and should not be interpreted independently of publication age, disciplinary citation practices, collaboration patterns, and database coverage.

Research impact may also include qualitative dimensions such as methodological contribution, advancement of scientific understanding, educational value, contribution to clinical or public-health knowledge, collaboration, data availability, and subsequent development by other researchers. Responsible research evaluation therefore benefits from a multidimensional approach. [4]

Award Suitability

The Best Research Article Award is intended to recognize an individual research article demonstrating substantive academic merit. Based on the supplied information, Ahmed Rabee has a documented research profile in Biomedical Sciences and an indexed scholarly record comprising three documents, five citations, and an h-index of 1. [1]

Suitability for article-level recognition should ultimately be determined through assessment of the nominated publication itself. Relevant considerations may include originality, clarity of the research question, methodological rigor, validity of results, ethical and scientific standards,[4]

Conclusion

Ahmed Rabee is a researcher affiliated with Sulaiman Alrajhi University, Saudi Arabia, with a documented scholarly profile in Biomedical Sciences. The supplied Google Scholar record identifies three documents, five citations, and an h-index of 1. [1]

The Best Research Article Award provides an appropriate framework for recognizing research that demonstrates scientific quality, relevance, originality, and contribution to its field. Final article-level assessment should be based on direct examination of the nominated publication and supporting scholarly evidence rather than bibliometric indicators alone.

References

    1. Google Scholar. Ahmed Rabee — Google Scholar author profile, Author ID KmgzUgEAAAAJ.
      https://scholar.google.com/citations?user=KmgzUgEAAAAJ&hl=en
    2. AR Rabee, M Gerges, et al. (2025). Photochromic spiroindolium iodide derivatives; synthesis, Molecular geometry DFT assessment and UV–vis photophysical investigation.
      https://www.sciencedirect.com/science/article/pii/S0022286025004260
    3. A Negm, AR Rabee, et al. (2025). Investigation of Quinoxaline-1,2,3-triazole Derivatives for Targeting SARS-CoV-2 via RBD Binding and PLpro Inhibition.
      https://link.springer.com/article/10.1134/S106816202460572X
    4. A Rabee, M Hamadan, et al. (2026). Advances in Exosome Engineering for Cardiovascular Applications.
      https://amb.cultechpub.com/amb/article/view/62

Hassan Malekinejad | Tissue Engineering Regeneration | Outstanding Contribution Award

Published on by Cell Biologist

Prof. Hassan Malekinejad | Tissue Engineering Regeneration | Outstanding Contribution Award

Urmia University of Medical Sciences | Iran

A senior academic in Pharmacology and Toxicology with advanced training in veterinary medicine and toxicology, complemented by two postdoctoral fellowships in public health and molecular pharmacology. Research focuses on tissue regeneration using nature-derived elements, with major contributions in aging, cancer biology, and wound healing. Extensive experience includes leading and contributing to aging-related research projects, publishing widely in SCI and Scopus-indexed journals, authoring a specialized book on animal cell culture, and holding patents under implementation. Actively involved in editorial responsibilities, international peer review, and professional toxicology associations.

Citation Metrics (Scopus)
4000
3000
2000
1000
500
100
0
Citations
3,607
Documents
136
h-index
30

Citations

Documents

h-index

Featured Publications

Jiangang Zhang | Cell Metabolism | Research Excellence Award

Published on by Cell Biologist

Dr. Jiangang Zhang | Cell Metabolism | Research Excellence Award

School of Basic Medical Sciences, Lanzhou University | China

Dr. Jiangang Zhang. A senior academic and medical professional with extensive leadership in pathology, forensic medicine, and laboratory sciences at Lanzhou University and its affiliated hospitals. Holds multiple directorial roles across pathology departments, forensic appraisal institutes, dental hospitals, and GLP laboratory centers, contributing significantly to clinical diagnostics, forensic evaluation, and translational research. Recognized nationally and provincially as an expert in forensic appraisal, including insurance-related forensic assessments, and plays a key role in expert review and governance bodies. Academic training spans clinical medicine, tissue engineering, and advanced biomedical research, with doctoral-level experience at Peking University. Research expertise includes obesity, nutrition, chronic diseases, skin tissue engineering, and pathology-related biomedical sciences. Has led and completed several major nationally funded research projects, including multiple grants from the National Natural Science Foundation of China and military medical research programs, reflecting sustained contributions to medical science, education, and forensic pathology.

Citation Metrics (Scopus)

300
200
100
50
0

Citations
252

Documents
14

h-index
6

Citations

Documents

h-index

Featured Publication

Jung Weon Lee | Tetraspanin-Mediated Liver Malignancy | Research Excellence Award

Published on by Cell Biologist

Prof. Jung Weon Lee | Tetraspanin-Mediated Liver Malignancy | Research Excellence Award

Seoul National University | South Korea

Jung Weon Lee is a distinguished researcher in pharmacology and biochemistry whose work integrates molecular pharmacology, biochemical pathway analysis, and disease-related mechanistic research. Trained across biochemical sciences and pharmacological disciplines, he has developed a robust program centered on understanding how cellular signaling networks, metabolic processes, and bioactive molecules regulate pathological conditions such as cancer, inflammation, and metabolic disorders. His research frequently explores the molecular basis of drug actions, enzyme regulation, and the interplay between biochemical pathways and disease progression. Through his faculty leadership at Seoul National University’s College of Pharmacy, he has advanced studies on cellular stress responses, protein modification systems, and molecular targets that influence cell survival, migration, and invasion. As a long-standing member of professional scientific societies and the Invadosome Consortium, he actively contributes to global investigations on cytoskeletal remodeling and matrix-degrading structures central to metastasis and tissue remodeling. His research group is known for integrating pharmacological assays with molecular and biochemical techniques to identify therapeutic candidates and elucidate mechanisms underlying disease-associated cellular behaviors. Overall, Lee’s scientific contributions strengthen translational links between biochemical research and pharmacological innovation, supporting the development of mechanism-based therapeutic strategies.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:  

  • Lee, Y., Kim, J. E., Kim, W., Kim, S., Han, R., Suh, D., Kim, E., Shin, E.-A., Pyo, K.-h., Lee, J.-H., Yoon, S., Kim, Y.-I., Cho, J.-Y., Choi, S., & Lee, J. W. (2025). Unique molecular architecture of N-glycosylated TM4SF5 dimer highlights evolutionary and structural divergence among small four-transmembrane protein families. Journal of Advanced Research. (In press)

  • Ahn, J., Kim, S., Jeong, J. Y., Heo, S., Pyo, K.-h., Shin, E.-A., Kim, W., Lee, J.-H., Choi, N. R., Lee, H.-A., Kim, H.-P., Song, S.-H., Kim, H. Y., Kim, T.-Y., & Lee, J. W. (2025). Whole genome DNA methylation patterns in tissue and cfDNA associated with fibrosis reflect the complex signature of MASLD. PLoS One, 20(7), e0328207.

  • Lee, H. S., Kim, J. E., Shin, E.-A., Pinanga, Y. D., Pyo, K.-h., Lee, E. H., Kim, W., Kim, S., Lim, C. S., Yoon, K. C., & Lee, J. W. (2025). Hepatocyte TM4SF5-mediated cytosolic NCOA3 stabilization and macropinocytosis support albumin uptake and bioenergetics for hepatocellular carcinoma progression. Experimental and Molecular Medicine, 57(4), 836–855.

  • Jin, S. H., Kim, D. J., & Lee, J. W. (2025). Tetraspan(in)-mediated immune regulation in hepatocellular carcinoma. Clinical and Molecular Hepatology, 31(2), 650–653.

  • Kim, J. E., Kim, H. S., Lee, E. H., Kim, W., Kim, S., Kim, T., Shin, E.-A., Pyo, K.-h., Lee, H., Jin, S. H., Lee, J.-H., Byeon, S.-M., Kim, D. J., Yu, S. J., Kim, S., Yoo, J. Y., Lee, S.-C., Suh, Y.-G., & Lee, J. W. (2025). Isoxazole-based molecules restore NK cell immune surveillance in hepatocarcinogenesis by targeting TM4SF5 and SLAMF7 linkage. Signal Transduction and Targeted Therapy, 10(1), 15.

Francesca Santilli | Signal Transduction Mechanisms | Research Excellence Award

Published on by Cell Biologist

Prof. Francesca Santilli | Signal Transduction Mechanisms | Research Excellence Award

Department of Medicine and Aging Science, University of Chieti-Pescara “G. d’Annunzio”Chieti | Italy

Francesca Santilli, MD, PhD, is a leading physician-scientist whose work has substantially advanced the understanding of platelet biology, thrombo-inflammation, and cardio-metabolic disease. Her research focuses on mechanisms of platelet activation, interindividual variability in response to low-dose aspirin, and the interplay between inflammation, oxidative stress, and metabolic dysfunction. She has led major national and international projects, including studies on oxidative stress regulation in aspirin-treated diabetes, peripheral blood megakaryocyte maturation, and the effects of JAK inhibitors on thrombopoiesis in inflammatory disease. Her work has also contributed key insights into biomarkers—such as proteomic signatures, microRNAs, and extracellular vesicles—for cardiovascular and metabolic risk stratification. Additional research explores megakaryocyte biology, accelerated platelet turnover, and the impact of emerging therapies including GLP-1 receptor agonists, SGLT2 inhibitors, and PCSK9 inhibitors. Through extensive collaborations across molecular medicine, proteomics, rheumatology, cardiology, and infectious diseases, she has established interdisciplinary frameworks linking platelet function to diabetes, obesity, MASLD, and vascular disease. With over 160 high-impact publications and leadership roles in several scientific networks, her research continues to inform clinical translation and therapeutic optimization in thrombosis, hemostasis, and metabolic disorders.

Profiles: Google Scholar | Scopus

Featured Publications: 

antilli, F., Vazzana, N., Liani, R., Guagnano, M. T., & Davì, G. (2012). Platelet activation in obesity and metabolic syndrome. Obesity Reviews, 13(1), 27–42.

Santilli, F., Rocca, B., De Cristofaro, R., Lattanzio, S., Pietrangelo, L., Habib, A., & Patrono, C. (2009). Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: Implications for aspirin “resistance.” Journal of the American College of Cardiology, 53(8), 667–677.

Rocca, B., Santilli, F., Pitocco, D., Mucci, L., Petrucci, G., Vitacolonna, E., … & Patrono, C. (2012). The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. Journal of Thrombosis and Haemostasis, 10(7), 1220–1230.

Caricato, A., Conti, G., Della Corte, F., Mancino, A., Santilli, F., Sandroni, C., … & Antonelli, M. (2005). Effects of PEEP on the intracranial system of patients with head injury and subarachnoid hemorrhage: The role of respiratory system compliance. Journal of Trauma and Acute Care Surgery, 58(3), 571–576.

Santilli, F., Vazzana, N., Bucciarelli, L. G., & Davì, G. (2009). Soluble forms of RAGE in human diseases: Clinical and therapeutical implications. Current Medicinal Chemistry, 16(8), 940–952.

Di Castelnuovo, A., Bonaccio, M., Costanzo, S., Gialluisi, A., Antinori, A., … Santilli, F., … & Iacoviello, L. (2020). Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: Survival analysis and machine learning-based findings from the multicentre Italian study. Nutrition, Metabolism and Cardiovascular Diseases, 30(11), 1899–1913.

Vazzana, N., Santilli, F., Cuccurullo, C., & Davì, G. (2009). Soluble RAGE in internal medicine. Internal and Emergency Medicine, 4(5), 389–401.

Davì, G., Santilli, F., & Patrono, C. (2010). Nutraceuticals in diabetes and metabolic syndrome. Cardiovascular Therapeutics, 28(4), 216–226.

Chiarelli, F., Santilli, F., & Mohn, A. (2000). Role of growth factors in the development of diabetic complications. Hormone Research in Paediatrics, 53(2), 53–67.

Davì, G., Chiarelli, F., Santilli, F., Pomilio, M., Vigneri, S., Falco, A., … & Basili, S. (2003). Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: Role of interleukin-6 and disease duration. Circulation, 107(25), 3199–3203.

Manigrasso, M. R., Ferroni, P., Santilli, F., Taraborelli, T., Guagnano, M. T., … & Davì, G. (2005). Association between circulating adiponectin and interleukin-10 levels in android obesity: Effects of weight loss. The Journal of Clinical Endocrinology & Metabolism, 90(10), 5876–5879.

Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Published on by Cell Biologist

Prof. Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Mazandaran University of Medical Sciences, Sari, Iran

Dr. Hamidreza Mohammadi is a researcher specializing in toxicology, pharmacology, and nanomedicine, with extensive work focused on the toxicological and therapeutic applications of nanomaterials. His research spans multiple domains including nanotoxicology, polymer therapeutics, clinical and food toxicology, and the development of safer nanopharmaceuticals. He has contributed to advancing the understanding of how engineered nanomaterials interact with biological systems, emphasizing risk assessment, cellular mechanisms of toxicity, and strategies for biocompatibility improvement. Dr. Mohammadi’s studies also explore the design of polymer-based drug delivery systems with enhanced therapeutic efficacy and reduced side effects. His work integrates experimental and applied toxicology to bridge laboratory research with clinical practice, contributing to public health and safety in pharmacological sciences. With interdisciplinary expertise covering both environmental and clinical toxicology, his research aligns with global priorities in nanomedicine innovation and toxicological risk evaluation. His scholarly efforts continue to support the development of next-generation nanotherapeutics with optimized pharmacokinetics and minimized toxic responses, reinforcing the importance of safe and sustainable nanotechnology in medical and pharmaceutical applications.

Profile: Orcid

Featured Publications:

Mokhtari Azad, T., Mohammadi, H., Moosavi, A., Saadatmand, Z., & Nategh, R. (2004). Influenza surveillance in the Islamic Republic of Iran from 1991 to 2001. Eastern Mediterranean Health Journal, 10(3), 315–321.

Cheraghali, A. M., Mohammadi, H. R., Amirahmadi, M., Yazdanpanah, H., Abouhossain, G., & Zamanian, F. (2005). Incidence of patulin contamination in apple juice produced in Iran. Food Control, 16(2), 165–167.

Shafiee, H., Mohammadi, H., Rezayat, S. M., Hosseini, A., Baeeri, M., & Hassani, S. (2010). Prevention of malathion-induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium-carrying nanoparticle. Toxicology Mechanisms and Methods, 20(9), 538–543.

Mohammadi, H., Karimi, G., Rezayat, S. M., Reza, A., Shafiee, H., & Nikfar, S. (2011). Benefit of nanocarrier of magnetic magnesium in rat malathion-induced toxicity and cardiac failure using non-invasive monitoring of electrocardiogram and blood pressure. Toxicology and Industrial Health, 27(5), 417–429.

Soltani, M., Shetab-Boushehri, S. F., Mohammadi, H., & Shetab-Boushehri, S. V. (2013). Proposing boric acid as an antidote for aluminium phosphide poisoning by investigation of the chemical reaction between boric acid and phosphine. Journal of Medical Hypotheses and Ideas, 7(1), 21–24.

Nestor Garcia | Cellular Stress Response | Best Academic Researcher Award

Published on by Cell Biologist

Prof. Dr. Nestor Garcia | Cellular Stress Response | Best Academic Researcher Award

CONICET | Argentina

Dr. Néstor Horacio García, MD, PhD, is a physician-scientist specializing in nephrology and vascular research with a strong focus on renal physiology, hypertension, and phosphate homeostasis. He earned his medical and doctoral degrees from the National University of Córdoba, complemented by advanced research training at the Henry Ford Hospital in the United States, where he investigated mechanisms related to hypertension and vascular regulation. His postdoctoral fellowship at the Mayo Foundation in Rochester, Minnesota, further deepened his expertise in phosphate metabolism and kidney function. Dr. García has served as a Research Clinical Associate in the Nephrology Department at Sanatorium Mayo, Córdoba, where he has acted as Principal Investigator for multiple pharmaceutical protocols and clinical studies. He has also contributed to Inspiranox Therapeutics Corporation as a medical scientist and clinical research consultant, engaging in translational and therapeutic innovation. His research explores the pathophysiology of kidney disease, the molecular regulation of blood pressure, and protective mechanisms against diabetic renal dysfunction. Recognized nationally and internationally, Dr. García has received multiple awards for excellence in basic nephrology research, including honors from the Argentine Society of Hypertension and the Latin American Society of Nephrology and Hypertension (SLANH).

Profile: Orcid

Featured Publications:

García, N. H. (2021). An intensive follow-up in subjects with cardiometabolic high-risk. Nutrition, Metabolism and Cardiovascular Diseases.

García, N. H. (2021). Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease. Stroke, 52(5), e125–e132.

García, N. H. (2020). Monosialoganglioside GM1 reduces toxicity of Ptx and increases anti-metastatic effect in a murine mammary cancer model. Scientific Reports, 10(1), 10645.

García, N. H. (2020). Ibuprofen, a traditional drug that may impact the course of COVID-19: New effective formulation in nebulizable solution. Medical Hypotheses, 144, 110079.

García, N. H. (2020). Eicosapentaenoic acid prevents salt sensitivity in diabetic rats and decreases oxidative stress. Nutrition, 79–80, 110644.

Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Dr. Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Shuxin Han | Xinjiang University | China

Dr. Shuxin Han is a distinguished molecular biologist and professor at Xinjiang University, widely recognized for his pioneering work in hepatobiliary and metabolic biology. With a research career spanning over two decades, Dr. Han has made major contributions to understanding how Kruppel-like factors, especially KLF15, regulate endobiotic and xenobiotic metabolism, impacting drug detoxification and metabolic disease mechanisms. He earned his Ph.D. from Kent State University and has held prestigious positions at Harvard Medical School and Case Western Reserve University. His groundbreaking studies have been published in high-impact journals like Nature Metabolism and Nature Communications, with several articles naming him as first or corresponding author. In addition to research, Dr. Han serves as a reviewer for top-tier journals in pharmacology, hepatology, and clinical science. He is also an academic leader, currently shaping the next generation of scientific talent and metabolic disease research in China.

Publication Profile: 

Scopus

Education:

Dr. Shuxin Han began his academic journey in Animal Sciences, earning a bachelor’s degree from Anhui Agricultural University (1994–1998). He advanced to a research assistant role at Peking University (1999–2000), where he deepened his scientific foundation. He then moved to the U.S. to pursue a Master’s in Biology at Temple University (2000–2003), followed by a Ph.D. in Molecular Biology from Kent State University (2004–2009), focusing on metabolic biology and gene regulation. This progression from general animal sciences to highly specialized molecular biology reflects a systematic and deep commitment to biomedical research. His strong academic preparation laid the foundation for a research career investigating how transcriptional regulators impact health and disease. Dr. Han’s training spans world-class institutions across both China and the United States, equipping him with diverse scientific perspectives and techniques.

Experience:

Dr. Shuxin Han has accumulated rich research and academic experience over nearly 30 years. His early career included a pivotal research assistant role at Peking University, followed by advanced training in biology and molecular biology at Temple and Kent State Universities. He completed prestigious postdoctoral training at Harvard Medical School (2009–2012) and Case Western Reserve University (2012–2015), where he later became a Senior Research Associate (2015–2019). He returned to China in 2019 as a Researcher at the University of Science and Technology of China First Affiliated Hospital, simultaneously engaging in academic duties at the university until 2023. Currently, he serves as a Professor and Academic Leader at Xinjiang University. Throughout his career, Dr. Han has built strong international collaborations, led research groups, and guided innovative projects in metabolic biology, demonstrating his leadership, research excellence, and academic mentorship capabilities.

Research Focus:

Dr. Shuxin Han’s research centers on the molecular regulation of metabolism, particularly focusing on the hepatobiliary and gastrointestinal systems. His work has elucidated the critical role of the Kruppel-like factor (KLF) family, especially KLF15, in controlling endobiotic and xenobiotic metabolism (EXM). These pathways govern how the body metabolizes both internal compounds and external substances like drugs. Dr. Han’s studies have shown that KLF15 acts as a master regulator, influencing drug resistance, liver injury, and metabolic homeostasis. His discoveries offer new insight into personalized medicine and treatment for metabolic disorders and drug-related toxicities. With numerous first-author and corresponding-author publications in journals such as Nature Metabolism, Nature Communications, and Drug Metabolism and Disposition, his work has significantly impacted both fundamental science and clinical applications. He is also active in peer-reviewing for top-tier journals and is recognized for his leadership in translational research.

Publications Top Notes:

  1. Unveiling KLF15 as the Key Regulator of Cyclosporine A Metabolism and Adverse Effects – Drug Metabolism and Disposition, 2025

  2. Distribution and Functional Significance of KLF15 in Mouse Cerebellum – Molecular Brain, 2025

  3. Personalized Statin Therapy: Targeting Metabolic Processes – Heliyon, 2025

  4. Current Status and New Directions for Hepatocellular Carcinoma Diagnosis – Liver Research, 2024

  5. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury – Drug Metabolism and Disposition, 2024

  6. Advancing Drug Delivery and Bioengineering in Liver Research – Bioengineering and Translational Medicine, 2024

  7. Advances in IL-7 Research on Tumor Therapy – Pharmaceuticals, 2024 (Co-author)

  8. Pathogenic Mechanisms in Alcoholic Liver Disease – Journal of Translational Medicine, 2023

  9. Beta-Hydroxybutyrate Effects on iPSC-Derived Cardiac Myocytes – Biomolecules, 2022

  10. Interactions Between Intestinal Flora and Bile Acids – International Journal of Molecular Sciences, 2022 (Corresponding author)

Conclusion:

In conclusion, Dr. Shuxin Han is a highly deserving candidate for the Best Researcher Award. His pioneering work on KLF15 and metabolic regulation has reshaped fundamental understanding in the field of hepatobiliary biology and pharmacology. His academic background, research productivity, international experience, and editorial service all reflect a well-rounded and impactful scientist. While there is room to increase clinical translation and international engagement, the depth, originality, and consistency of his research make him a strong contender for this recognition. Honoring Dr. Han with this award would acknowledge a career dedicated to scientific advancement with substantial implications for human health and drug therapy.

Nabil Alshurafa | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Prof. Nabil Alshurafa | Molecular Mechanisms Signaling | Best Researcher Award

Prof. Nabil Alshurafa, Northwestern University, United States

Dr. Nabil Alshurafa is a tenured Associate Professor at Northwestern University’s Feinberg School of Medicine in the Department of Preventive Medicine. A recognized expert in wearable health technology and artificial intelligence, his work bridges computer science and preventive health. With a strong foundation in AI, embedded systems, and wireless health, Dr. Alshurafa is known for pioneering research that transforms how chronic conditions are monitored remotely. He has held prestigious fellowships, serves on influential editorial boards, and contributes actively to global conferences. Passionate about advancing digital health, his interdisciplinary approach fosters innovation in non-invasive health monitoring technologies. His body of work, including over 100 peer-reviewed publications and several with high citation metrics, has significantly shaped mobile and wearable health sensing technologies. Known for collaborative leadership and visionary research, he continues to inspire advancements in AI-driven healthcare.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Innovative Research Focus:
    Dr. Alshurafa is a pioneer in AI-powered wearable health technologies, focusing on practical, non-invasive solutions for chronic disease management, nutrition monitoring, and human activity recognition.

  2. High-Impact Publications:
    His publications are well-cited, including several landmark works like “Deep learning in human activity recognition…” and “NeckSense…” that demonstrate translational value in digital health and mobile sensing.

  3. Prestigious Roles & Affiliations:
    Editorial roles with ACM IMWUT, IEEE, and Nature Digital Medicine, along with organizational roles in IEEE PerCom, underscore his peer recognition and leadership in the field.

  4. Award-Winning Work:
    His research has received Best Paper Awards and has been presented at highly selective conferences with acceptance rates as low as 10–25%.

  5. Interdisciplinary Impact:
    His work intersects computer science, biomedical engineering, and preventive medicine, which is critical in tackling modern healthcare challenges through integrated technology.

  6. Real-World Applications:
    Tools like WANDA, NeckSense, and smart bedsheets reflect direct applicability to patient care and wellness monitoring.

🔧 Areas for Improvement:

  1. Global Visibility:
    While his national recognition is strong, increasing presence in international healthcare policy and standards bodies could elevate his global influence.

  2. Cross-Sector Translation:
    Although academically impactful, more visible industry collaborations or commercial deployments (e.g., FDA-approved products or spin-offs) would enhance the translational credibility of his work.

  3. Public Engagement:
    Expanding outreach through public talks, tech-for-health summits, or popular science channels would help bring his innovations closer to everyday users and clinicians.

  4. Broader Health Diversity Applications:
    More research could be targeted toward underserved populations or global health settings, showcasing scalability and equity of the solutions.

🎓 Education:

Dr. Nabil Alshurafa began his academic journey at the University of California, Los Angeles (UCLA), earning a Bachelor of Science in Computer Science in 2003 with summa cum laude honors. He further pursued graduate education at UCLA, receiving his Master of Science in Computer Science in 2010 with a specialization in Artificial Intelligence. His graduate work laid the foundation for his future contributions in AI-powered healthcare. To gain applied research experience, he joined UCLA’s Wireless Health Institute from 2013 to 2015 as a Wireless Health Fellow. This multidisciplinary training equipped him with expertise in sensor technology, machine learning, and biomedical systems. The academic rigor and technological immersion at UCLA played a pivotal role in shaping his research direction—particularly in remote health monitoring and ubiquitous computing, which have become the hallmarks of his career.

🧪 Experience:

Dr. Alshurafa’s career spans academia, research, and editorial leadership. Since 2022, he has served as a tenured Associate Professor at Northwestern University, where he leads innovative projects in wearable computing and health analytics. His prior fellowship at UCLA’s Wireless Health Institute (2013–2015) was instrumental in honing his applied skills in biomedical sensing and embedded AI systems. He has contributed to multiple high-impact research studies, demonstrating leadership in both collaborative and solo research environments. Beyond teaching and mentoring, Dr. Alshurafa plays a key role in global health informatics networks, serving on editorial boards such as ACM IMWUT, PLOS ONE, and Nature Digital Medicine. His industry engagement is evident from his organizational roles at IEEE PerCom, where he has served as Industry Track Chair and Sponsorship Chair. These roles reflect his commitment to bridging academia with real-world technological solutions in preventive and mobile health.

🏅 Awards and Honors:

Dr. Alshurafa has been recognized for his academic excellence and leadership in health informatics. He is a member of ACM and has held key editorial positions in ACM Interactive, Mobile, Wearable, and Ubiquitous Computing (IMWUT). His roles with IEEE PerCom as Industry Track Chair (2018) and Sponsorship Chair (2019) highlight his prominence in mobile health computing communities. His research has been distinguished with honors such as Best Paper Award at the IEEE International Conference on Wearable and Implantable Body Sensor Networks (BSN). Additionally, several of his publications have been widely cited, underscoring his influence in the field. His editorial board memberships across journals like PLOS ONE, IEEE Biomedical Health Informatics, and Nature Digital Medicine showcase peer recognition of his expertise. Collectively, these accolades reflect a sustained and impactful contribution to health technologies and interdisciplinary research.

🔬 Research Focus:

Dr. Nabil Alshurafa’s research centers on AI-driven wearable technologies for remote health monitoring and behavioral health sensing. He focuses on building unobtrusive, sensor-based systems that can track physiological signals and behaviors such as eating, physical activity, and sleep in real-world environments. By integrating machine learning with low-power embedded systems, he develops scalable tools for chronic disease management, including heart failure and diabetes. His work leverages signal processing, stochastic modeling, and deep learning to transform raw sensor data into clinically actionable insights. A key contribution is his development of NeckSense, a multi-sensor necklace for detecting eating behaviors, and WANDA, an end-to-end health monitoring system. Through interdisciplinary collaborations, he also explores nutrition sensing, exergaming, and rehabilitation technologies. His ultimate goal is to enable proactive, personalized healthcare solutions that reduce the burden on patients and providers alike while enhancing wellness through smart, wearable ecosystems.

📚 Publications Top Notes: 

  1. 🕷️ Artificial Spider: Eight-legged arachnid and autonomous learning of locomotion

  2. ❤️ WANDA: An end-to-end remote health monitoring and analytics system for heart failure patients

  3. 🔋 Opportunistic hierarchical classification for power optimization in wearable movement monitoring systems

  4. 🩺 Dynamic task optimization in remote diabetes monitoring systems

  5. 😴 Inconspicuous on-bed respiratory rate monitoring

  6. 🛏️ A dense pressure sensitive bedsheet design for unobtrusive sleep posture monitoring

  7. 👕 Improving accuracy in E-Textiles as a platform for pervasive sensing

  8. 🚶 Robust human intensity-varying activity recognition using Stochastic Approximation in wearable sensors

  9. 🏋️ On-bed monitoring for range of motion exercises with a pressure sensitive bedsheet

  10. 🎮 MET calculations from on-body accelerometers for exergaming movements

🧾 Conclusion:

Dr. Nabil Alshurafa stands out as an exceptionally qualified candidate for the Best Researcher Award. His work embodies the intersection of innovation, application, and societal benefit. He has demonstrated leadership in both research productivity and community contribution, with a track record that is not only prolific but also highly relevant to the future of preventive and digital healthcare. His pioneering systems in wearable health monitoring have the potential to transform how health is tracked and managed in real time, offering personalized insights and clinical utility.

Noura Hussein Abdel Hamid | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Noura Hussein Abdel Hamid | Cell Structure Analysis | Best Researcher Award

Assist. Prof. Dr. Noura Hussein Abdel Hamid , Zagazig University , Egypt

Dr. Noura Hussein Abedel Hamid Mekawy is a dedicated Egyptian medical academic with extensive expertise in Histology and Cell Biology. Born on April 18, 1981, she graduated with an M.B.B.Ch. from Zagazig University in 2006, followed by a Master’s (2012) and an M.D. (2017) in Histology and Cell Biology from the same institution. Currently, she serves as a Lecturer at Zagazig University’s Faculty of Medicine. Her academic journey is complemented by her passion for medical education, microscopy, and molecular research. Dr. Mekawy has contributed to the field with multiple publications in reputable scientific journals, focusing on histopathological and immunohistochemical studies. She is a member of the Egyptian Society of Histology and Cytology and has completed professional training in self-evaluation and quality assurance in higher education. Her commitment to scientific advancement and education has established her as a respected figure in medical academia.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Extensive Research Background
    Dr. Mekawy has authored and co-authored 10 peer-reviewed publications, focusing on histopathology, immunohistochemistry, toxicology, and therapeutic interventions in experimental models.

  2. Specialization in a Vital Medical Field
    Her focus on Histology and Cell Biology is crucial for understanding disease mechanisms and developing new treatment strategies.

  3. Academic Progression & Teaching Role
    She has shown consistent career advancement from Demonstrator to Lecturer, demonstrating leadership and commitment in academia.

  4. Diverse Research Themes
    Her work explores the toxicological impacts of nanoparticles, pharmaceuticals, and environmental exposures, as well as the protective effects of antioxidants and stem cells—offering a well-rounded scientific profile.

  5. Professional Engagement
    Active member of Egyptian Society of Histology and Cytology and Medical Professions Syndicate, and involved in scientific conferences and training workshops.

  6. Methodological Strength
    Her skills in light/electron microscopy and immunohistochemical techniques indicate deep technical expertise.

⚙️ Areas for Improvement:

  1. Expand to International Collaborations
    Engaging in collaborative research with international institutions can increase visibility and impact.

  2. Publication in Higher Impact Journals
    While she has multiple publications, targeting high-impact Q1 journals can elevate the academic value of her research.

  3. Grant Funding & Project Leadership
    Applying for external research grants and leading funded projects would further enhance her research profile.

  4. Clinical Translation
    Bridging her findings from animal studies to clinical or translational research can broaden applicability.

🎓 Education:

Dr. Noura Mekawy earned her M.B.B.Ch. degree in Medicine and General Surgery from Zagazig University in October 2006, graduating with an excellent grade. Her strong academic foundation led her to pursue postgraduate studies in Histology and Cell Biology. In May 2012, she was awarded a Master’s degree with a thesis titled “The Effect of Maternal Exposure to Di (2-ethylhexyl) phthalate on The Lung of Albino Rat Offspring (Histological and Immunohistochemical Study).” She continued her academic progression by earning her M.D. in Basic Medical Sciences (Histology and Cell Biology) in January 2017. Throughout her studies, Dr. Mekawy demonstrated outstanding academic performance and developed a deep interest in cellular biology and histopathology. Her educational background reflects her commitment to advancing medical science through both practical research and academic instruction.

🧪 Experience:

Dr. Noura Mekawy began her academic career as a Demonstrator in the Histology and Cell Biology Department at Zagazig University in August 2008. She served in this role until May 2012, when she was promoted to Assistant Lecturer. In January 2017, following the completion of her M.D., she assumed the position of Lecturer in the same department. With over 15 years of experience in teaching and laboratory work, Dr. Mekawy has become proficient in histological techniques, immunohistochemistry, and electron microscopy. She is also skilled in data analysis using SPSS and Microsoft Office tools. Her responsibilities include teaching, supervising research projects, and contributing to curriculum development. Additionally, she has participated in educational quality assurance workshops and continues to mentor students and junior faculty members. Her teaching experience, combined with hands-on laboratory expertise, makes her a well-rounded educator and researcher.

🔬 Research Focus:

Dr. Mekawy’s research primarily focuses on histopathological and immunohistochemical changes in response to environmental, chemical, and pharmaceutical exposures in animal models. Her investigations are centered on understanding tissue damage and repair mechanisms in organs like the liver, lungs, testes, heart, submandibular glands, and the central nervous system. A consistent theme across her work is evaluating the protective or therapeutic roles of natural substances and pharmacological agents, including antioxidants like Vitamin E, Nigella sativa, and Zingerone, as well as advanced treatments such as salivary exosomes and stem cells. She integrates light microscopy, electron microscopy, and molecular biology techniques in her research. Dr. Mekawy is also engaged in evaluating the histological effects of nanoparticles and energy drinks on various tissues. Her contributions are valuable for toxicological assessment and potential therapeutic innovations, contributing to public health and medical safety.

📚 Publications Top Notes:

  1. 🧪 Effect of Silver Nanoparticles on Testes of Prepubertal Male Albino Rats and the Possible Protective Role of Vitamin E

  2. ⚠️ Hepatic Changes under the Effect of Red Bull Energy Drinks and its Withdrawal in Adult Male Albino Rats

  3. 💧 Therapeutic Role of Salivary Exosomes in Improving Histological and Biochemical Changes Induced by Duct Ligation in Submandibular Glands

  4. ❤️ The Possible Protective Effect of Zingiber Officinale on Cyclophosphamide-Induced Cardiotoxicity

  5. 👁️ Protective Effect of Chrysin on Corneal Structural Alterations Induced by Sofosbuvir

  6. 🧬 Nicorandil and Bone Marrow-Derived Mesenchymal Stem Cells in Ureteric Obstruction Recovery

  7. 🧠 Effect of Zinc Oxide Nanoparticles on Cerebellar Cortex of Adult Male Albino Rats

  8. 🥼 Protective Role of Ghrelin versus its Combination with Zingerone on Gastric Ischemic-Reperfusion

  9. 🔊 Effect of Low Frequency Noise on Heart and Lung & Role of Vitamin C

  10. 💪 Nandrolone Effect on Cardiac Muscle and Role of Nigella Sativa

🧾 Conclusion:

Dr. Noura Mekawy exhibits the hallmarks of a dedicated, capable, and innovative researcher in medical science. With over a decade of academic and research experience, she has made valuable contributions to experimental histology and cell biology. Her work is methodologically sound, thematically diverse, and medically relevant. The strength of her research, consistent publication record, and academic integrity make her a highly suitable candidate for the Best Researcher Award. Continued growth in publication quality, global collaboration, and translational research will further enhance her already impressive academic journey.